• Ear Health Reimagined

  • Game Changing

    OtoScan helps to determine the presence or absence of fluid in the middle ear, characterize the type of fluid, visualize the fluid’s density, and can do all of this even in the presence of significant wax.

  • Limiting Uncertainty

    With objective data, healthcare providers now have more information to increase confidence in their treatment plan.

  • Reduced Costs

    A novel technology capable of helping clinicians make better decisions leading to improved outcomes and quicker time to restored ear health.

Impactful Innovation

  • 01

    Compact, approachable design

    • Familiar, handheld device reassures patients
    • Adjustable, mobile, all-in-one unit
    • Stand-based for easy movement
    • Small footprint taking up minimal space in the clinic
    • Any healthcare provider can utilize the device with confidence.
  • 02

    Demonstrable impact on care

    • Objective data derived from the middle ear helps to address underlying ear health issues
    • Potential to more appropriately prescribe antibiotics
    • Can provide objective data to aid in the assessment of hearing loss, chronic ear infections, and resulting learning disabilities
  • 03

    Two views of the ear

    • True color video otoscope view of the ear canal and eardrum
    • OtoScan helps to determine the presence or absence of fluid in the middle ear, characterize the type of fluid, visualize the fluid’s density, and can do all of this even in the presence of significant wax
  • 04

    Taking the guesswork out of ear health

    • OtoScan provides an objective assessment of middle ear health.
    • OtoSight results are not minimally affected by user or patient variability.
    • OtoSight Middle Ear Scope technology is 90.6% accurate when assessing middle ear effusion (fluid)
  • This startup has good news you’ll want to hear -and read – all about

    Originally published by WRAL TechWire by Bryant Haskins, NCBiotech writer… Read More

  • Dr Novak and Patient using OtoSight

    PhotoniCare Announces Rebranding of First-in-Class Technology for Imaging the Middle Ear, Now called OtoSight Middle Ear Scope

    Champaign, IL – PhotoniCare, Inc., a company dedicated to revolutionizing healthcare… Read More

  • PhotoniCare Announces More Than $7 Million in Funding for Commercial Expansion of First-In-Class Ear Imaging Technology

    Pharmaceutical and medical device leader Jeff Hydar named Chief Commercial… Read More